Fluticasone propionate and Salmeterol combination induces SOCS-3 expression in airway epithelial cells

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 217-225

  Nasreen, Najmunnisa ^a,b   Khodayari, Nazli ^a,b   Sukka Ganesh, Bhagyalaxmi ^a,b   Peruvemba, Sriram ^a,b   Mohammed, Kamal A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

COPD; Erk1 Erk2 MAP kinase; Fluticasone propionate; p38 MAP kinase; SOCS 3

Indexed keywords

FLUTICASONE PROPIONATE; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; SALMETEROL XINAFOATE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOBACCO SMOKE;

ARTICLE; BRONCHIAL AIRWAY EPITHELIAL CELL; BRONCHUS MUCOSA; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; DRUG SCREENING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALBUTEROL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BRONCHI; CELL LINE; CELLS, CULTURED; DRUG COMBINATIONS; EPITHELIAL CELLS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASES; RNA, MESSENGER; SMOKE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOBACCO;

EID: 84856087326     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.11.014     Document Type: Article

References (50)

1. P.M. Calverley, and P. Walker Chronic obstructive pulmonary disease Lancet 362 2003 1053 1061 (Pubitemid 37186885)
2. E.R. Sutherland, and R.J. Martin Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma J Allergy Clin Immunol 112 2003 819 827 quiz 28
3. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary Am J Respir Crit Care Med 163 2001 1256 1276 (Pubitemid 32378468)
4. J.B. Soriano, J. Vestbo, N.B. Pride, V. Kiri, C. Maden, and W.C. Maier Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice Eur Respir J 20 2002 819 825 (Pubitemid 35175115)
5. E. Ceylan Budesonide-formoterol (inhalation powder) in the treatment of COPD Int J Chron Obstruct Pulmon Dis 1 2006 115 122
6. D.A. Mahler, P. Wire, D. Horstman, C.N. Chang, J. Yates, and T. Fischer Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 1084 1091 (Pubitemid 35178706)
7. N.C. Barnes, Y.S. Qiu, I.D. Pavord, D. Parker, P.A. Davis, and J. Zhu Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease Am J Respir Crit Care Med 173 2006 736 743
8. M. Marini, E. Vittori, J. Hollemborg, and S. Mattoli Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma J Allergy Clin Immunol 89 1992 1001 1009
9. A. Tobler, R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M.F. Fey Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts Blood 79 1992 45 51
10. M. Ohnishi, R. Takizawa, K. Ohkubo, K. Yokosima, M. Okuda, and T. Yagi Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells Allergy 43 1994 441 447 (Pubitemid 24151623)
11. M.P. Hallsworth, C.H. Twort, T.H. Lee, and S.J. Hirst Beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells Br J Pharmacol 132 2001 729 741 (Pubitemid 32165189)
12. R. Schickel, B. Boyerinas, S.M. Park, and M.E. Peter MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene 27 2008 5959 5974
13. C.J. Whelan, M. Johnson, and C.J. Vardey Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung Br J Pharmacol 110 1993 613 618 (Pubitemid 23279268)
14. N.J. Vanacker, E. Palmans, R.A. Pauwels, and J.C. Kips Effect of combining salmeterol and fluticasone on the progression of airway remodeling Am J Respir Crit Care Med 166 2002 1128 1134 (Pubitemid 35178713)
15. R. Dahl, A. Chuchalin, D. Gor, S. Yoxall, and R. Sharma EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma Respir Med 100 2006 1152 1162 (Pubitemid 43809959)
16. L. Pang, and A.J. Knox Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells Am J Respir Cell Mol Biol 23 2000 79 85 (Pubitemid 30597098)
17. W.J. Leonard, and J.J. O'Shea Jaks and STATs: biological implications Annu Rev Immunol 16 1998 293 322 (Pubitemid 28183367)
18. U. Hemmann, C. Gerhartz, B. Heesel, J. Sasse, G. Kurapkat, and J. Grotzinger Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation J Biol Chem 271 1996 12999 13007
19. J.G. Bode, A. Nimmesgern, J. Schmitz, F. Schaper, M. Schmitt, and W. Frisch LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages FEBS Lett 463 1999 365 370 (Pubitemid 30001952)
20. R. Starr, T.A. Willson, E.M. Viney, L.J. Murray, J.R. Rayner, and B.J. Jenkins A family of cytokine-inducible inhibitors of signalling Nature 387 1997 917 921 (Pubitemid 27289594)
21. A.H. Dalpke, S. Opper, S. Zimmermann, and K. Heeg Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs J Immunol 166 2001 7082 7089 (Pubitemid 32525577)
22. F. Magrangeas, O. Boisteau, S. Denis, Y. Jacques, and S. Minvielle Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3) Biochem J 353 2001 223 230 (Pubitemid 32096929)
23. B.A. Croker, H. Kiu, M. Pellegrini, J. Toe, S. Preston, and D. Metcalf IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3 Immunol Cell Biol 2011 1 6
24. Z. Xiong, A.S. Leme, P. Ray, S.D. Shapiro, and J.S. Lee CX3CR1 + lung mononuclear phagocytes spatially confined to the interstitium produce TNF-alpha and IL-6 and promote cigarette smoke-induced emphysema J Immunol 186 2011 3206 3214
25. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688 (Pubitemid 37258549)
26. D.D. Sin, and S.F. Man Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients? Curr Opin Pulm Med 13 2007 90 97 (Pubitemid 46178288)
27. D.D. Sin, S.F. Man, D.D. Marciniuk, G. Ford, M. FitzGerald, and E. Wong Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978] BMC Pulm Med 6 2006 3
28. P. Calverley, R. Pauwels, J. Vestbo, P. Jones, N. Pride, and A. Gulsvik Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 2003 449 456 (Pubitemid 36173708)
29. K.A. Mohammed, N. Nasreen, R.S. Tepper, and V.B. Antony Cyclical stretch induces PlGF expression in bronchial epithelial cells via nitric oxide release Am J Physiol Lung Cell Mol Physiol 292 2 2007 L559 L566
30. R. Aldonyte, M. Brantly, E. Block, J. Patel, and J. Zhang Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells Exp Lung Res 35 2009 59 75
31. N. Nasreen, K.A. Mohammed, K.K. Mubarak, M.A. Baz, O.A. Akindipe, and S. Fernandez-Bussy Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro Am J Physiol Lung Cell Mol Physiol 297 2009 L115 L124
32. M. Kubo, T. Hanada, and A. Yoshimura Suppressors of cytokine signaling and immunity Nat Immunol 4 2003 1169 1176 (Pubitemid 37540685)
33. A. Matsumoto, Y. Seki, R. Watanabe, K. Hayashi, J.A. Johnston, and Y. Harada A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production J Exp Med 197 2003 425 436 (Pubitemid 36278599)
34. J. Atsuta, J. Plitt, B.S. Bochner, and R.P. Schleimer Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids Am J Respir Cell Mol Biol 20 1999 643 650 (Pubitemid 129495652)
35. J.C. Chiu, J.Y. Hsu, L.S. Fu, J.J. Chu, and C.S. Chi Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells J Microbiol Immunol Infect Wei mian yu gan ran za zhi 40 2007 388 394
36. P.J. Barnes Molecular mechanisms and cellular effects of glucocorticosteroids Immunol Allergy Clin North Am 25 2005 451 468 (Pubitemid 41073456)
37. M. Fujita, J.M. Shannon, H. Ouchi, D.R. Voelker, Y. Nakanishi, and R.J. Mason Serum surfactant protein D is increased in acute and chronic inflammation in mice Cytokine 31 2005 25 33 (Pubitemid 40828355)
38. O.S. Usmani, K. Ito, K. Maneechotesuwan, M. Ito, M. Johnson, and P.J. Barnes Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy Am J Respir Crit Care Med 172 2005 704 712 (Pubitemid 41324225)
39. S. Escotte, O. Tabary, D. Dusser, C. Majer-Teboul, E. Puchelle, and J. Jacquot Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway Eur Respir J 21 2003 574 581 (Pubitemid 36432507)
40. P.R. Butchers, C.J. Vardey, and M. Johnson Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung Br J Pharmacol 104 1991 672 676
41. E.Y. Bissonnette, and A.D. Befus Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells J Allergy Clin Immunol 100 1997 825 831 (Pubitemid 28299003)
42. J. Kleine-Tebbe, G. Frank, C. Josties, and G. Kunkel Influence of salmeterol, a long-acting beta 2-adrenoceptor agonist, on IgE-mediated histamine release from human basophils J Investig Allergol Clin Immunol 4 1994 12 17 (Pubitemid 24123095)
43. J.A. Roberts, P. Bradding, K.M. Britten, A.F. Walls, S. Wilson, and C. Gratziou The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma Eur Respir J 14 1999 275 282 (Pubitemid 29461289)
44. C. Gomez-Guerrero, O. Lopez-Franco, G. Sanjuan, P. Hernandez-Vargas, Y. Suzuki, and G. Ortiz-Munoz Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury J Immunol 172 2004 6969 6977 (Pubitemid 38669137)
45. T. Shouda, T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, and K. Miyoshi Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J Clin Invest 108 2001 1781 1788 (Pubitemid 34015123)
46. Raghavendra Rao VL, Bowen KK, Dhodda VK, Song G, Franklin JL, Gavva NR, et al. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. Journal of neurochemistry 2002;83:1072-86. (Pubitemid 35397117)
47. J.C. Marine, C. McKay, D. Wang, D.J. Topham, E. Parganas, and H. Nakajima SOCS3 is essential in the regulation of fetal liver erythropoiesis Cell 98 1999 617 627 (Pubitemid 29418953)
48. H. Yasukawa, M. Hoshijima, Y. Gu, T. Nakamura, S. Pradervand, and T. Hanada Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways J Clin Invest 108 2001 1459 1467 (Pubitemid 33091983)
49. X.P. Yang, F. Schaper, A. Teubner, F. Lammert, P.C. Heinrich, and S. Matern Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo J Hepatol 43 2005 704 710 (Pubitemid 41253239)
50. E. Cazes, J. Giron-Michel, S. Baouz, C. Doucet, F. Cagnoni, and S. Oddera Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation J Immunol 167 2001 5329 5337 (Pubitemid 33009772)